MarketInOut Stock Screener Log In | Sign Up
 

Merck & Co Inc

MIL • Healthcare • Drug Manufacturers - General • Quote as of 07/28/2026 17:35
Merck & Co Inc stock price and volume chart

Company Profile

IndustryDrug Manufacturers - General
SectorHealthcare
ExchangeMIL
Market Capitalization271,187 mln
Float2,466 mln
Earnings Date04/30/2026

EPS

3.11
Stretched

P / E

37.90
Overvalued

Piotroski F-Score

4 / 9
Borderline

Beneish M-Score

-2.68
Likely reliable

Relative Strength

74 / 100
Outperforming

Debt / Equity

1.07
Elevated leverage

Business Description

Merck & Co., founded in 1891 and based in Rahway, New Jersey, is a global healthcare company that develops and sells medicines and vaccines for both people and animals. Its human health products cover a wide range of conditions, including cancer, infectious diseases, and sleep disorders, while its animal health division serves livestock farmers and pet owners with treatments, vaccines, and monitoring tools. The company also works alongside a number of partners, including AstraZeneca, Eisai, Moderna, and several others, to bring new therapies to market across oncology and other medical fields.

Key Fundamentals

EPS3.11
P/E37.90
ROE17.66
RPS22.68
ROIC10.96
ROA6.97
Interest Cover8.48
EBITDA, mln16,620
EV / EBITDA18.62
EV / EBIT27.47
Revenue, mln56,516
EV / Revenue5.49

Financial Strength

Altman Z-Score3.95
Piotroski F-Score 4 / 9
Beneish M-Score-2.68
Price to Intrinsic Value1.94
Price to Lynch Fair Value1.59
Shiller PE Ratio30.94

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 6.96% 87 / 100   
1 Month 18.27% 92 / 100   
2 Months 16.3% 79 / 100   
6 Months 36.72% 81 / 100   
1 Year 69.79% 84 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Contact Us